Finance

Lists
Why is 069620 up 2,67%?
Dive Deeper
069620:KRX
Daewoong Pharma
107 800,00 ₩
+2,67%
(+2 800,00) 1D
19 հոկ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 069620...
Open
105 300 ₩
High
108 500 ₩
Low
104 000 ₩
Mkt. cap
1,25 տրլն
Avg. vol.
19,18 հզր
Volume
16,00 հզր
Dividend
0,56%
Quarterly dividend
150 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
6,35
52-wk high
199 400 ₩
52-wk low
101 900 ₩
EPS
16 988 ₩
Shares outstanding
11,59 մլն
No. of employees
2 հզր
Open
105 300 ₩
High
108 500 ₩
Low
104 000 ₩
Mkt. cap
1,25 տրլն
Avg. vol.
19,18 հզր
Volume
16,00 հզր
Dividend
0,56%
Quarterly dividend
150 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
6,35
52-wk high
199 400 ₩
52-wk low
101 900 ₩
EPS
16 988 ₩
Shares outstanding
11,59 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
About Daewoong Pharma
CEOChang-jae Lee | Seongsoo Park
Employees1,89 հզր
Founded1945
Headquarters-
Sector-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
411,83 մլրդ
397,12 մլրդ
377,80 մլրդ
448,46 մլրդ
Cost of goods sold
198,11 մլրդ
185,96 մլրդ
196,61 մլրդ
199,39 մլրդ
Cost of revenue
198,11 մլրդ
185,96 մլրդ
196,61 մլրդ
199,39 մլրդ
Research and development expenses
8,31 մլրդ
139,98 մլրդ
16,11 մլրդ
14,81 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144,21 մլրդ
23,12 մլրդ
136,65 մլրդ
154,92 մլրդ
Operating expense
156,83 մլրդ
169,10 մլրդ
158,98 մլրդ
181,01 մլրդ
Total operating expenses
354,94 մլրդ
355,06 մլրդ
355,59 մլրդ
380,40 մլրդ
Operating income
56,89 մլրդ
42,06 մլրդ
22,21 մլրդ
68,07 մլրդ
Other non operating income
-1,16 մլրդ
2,77 մլրդ
1,52 մլրդ
-36,53 մլրդ
EBT including unusual items
54,73 մլրդ
68,97 մլրդ
33,97 մլրդ
21,89 մլրդ
EBT excluding unusual items
54,73 մլրդ
88,02 մլրդ
11,82 մլրդ
21,89 մլրդ
Income tax expense
7,42 մլրդ
-16,73 մլրդ
8,46 մլրդ
1,98 մլրդ
Effective tax rate
13,56%
-24,26%
24,89%
9,02%
Other operating expenses
1,17 մլրդ
1,17 մլրդ
1,88 մլրդ
1,61 մլրդ
Net income
46,37 մլրդ
89,84 մլրդ
25,90 մլրդ
33,37 մլրդ
Net profit margin
11,26%
22,62%
6,86%
7,44%
Earnings per share
-
-
-
-
Interest and investment income
-
1,12 մլրդ
1,74 մլրդ
-
Interest expense
-
-3,53 մլրդ
-8,00 մլրդ
-
Net interest expenses
-
-2,41 մլրդ
-6,26 մլրդ
-
Depreciation and amortization charges
1,77 մլրդ
1,43 մլրդ
1,15 մլրդ
7,94 մլրդ
EBITDA
69,45 մլրդ
56,04 մլրդ
38,38 մլրդ
92,95 մլրդ
Gain or loss from assets sale
-12,80 մլն
-52,31 մլրդ
35,01 մլն
-7,54 մլն
AI content may include mistakes. Learn more
Google Apps